• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出 4 个血浆 microRNAs,作为中国男性肺鳞癌患者诊断的潜在生物标志物。

Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.

机构信息

Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.

Department of Respiration, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 210000, China.

出版信息

Cancer Med. 2018 Jun;7(6):2370-2381. doi: 10.1002/cam4.1490. Epub 2018 Apr 19.

DOI:10.1002/cam4.1490
PMID:29673101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6010830/
Abstract

Dysregulated microRNAs (miRNAs) in the plasma of patients with lung squamous cell carcinoma (LSCC) might serve as biomarkers for LSCC diagnosis. The expression of miRNAs was performed using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) on the basis of Exiqon panels in the initial screening phase including three male LSCC pool samples and one normal control (NC) pool sample (per 10 samples were pooled as one pool sample). After the training (32 LSCC vs. 31 NCs), the testing (55 LSCC vs. 55 NCs), and the external validation (15 LSCC vs. 15 NCs) stages via qRT-PCR, a four-miRNA signature (miR-181a-5p, miR-21-5p, miR-106a-5p, and miR-93-5p) was identified for LSCC detection. Areas under the receiver operating characteristic (ROC) curve (AUC) of the four-miRNA panel for the training, the testing, and the external validation phases were 0.795, 0.827, and 0.914, respectively. Then, the four miRNAs were explored in LSCC tissue samples (23 LSCC vs. 23 NCs), and their expression was significantly up-regulated. However, none of the four miRNAs found significantly up-regulated in plasma exosomes expect miR-93-5p with borderline significance (16 LSCC vs. 16 NCs). In summary, our study established a four-miRNA peripheral plasma signature, which contributed to diagnosing male LSCC patients in China to a certain degree.

摘要

在肺鳞状细胞癌(LSCC)患者的血浆中失调的 microRNAs(miRNAs)可能作为 LSCC 诊断的生物标志物。在初始筛选阶段,根据 Exiqon 面板使用定量逆转录聚合酶链反应(qRT-PCR)进行 miRNA 的表达,包括三个男性 LSCC 池样本和一个正常对照(NC)池样本(每 10 个样本混合为一个池样本)。经过 qRT-PCR 的训练(32 例 LSCC 与 31 例 NC)、测试(55 例 LSCC 与 55 例 NC)和外部验证(15 例 LSCC 与 15 例 NC)阶段后,确定了用于 LSCC 检测的四 miRNA 特征(miR-181a-5p、miR-21-5p、miR-106a-5p 和 miR-93-5p)。该四 miRNA 面板在训练、测试和外部验证阶段的接收者操作特征(ROC)曲线下面积(AUC)分别为 0.795、0.827 和 0.914。然后,在 LSCC 组织样本(23 例 LSCC 与 23 例 NC)中探索了这四个 miRNA,发现它们的表达显著上调。然而,除 miR-93-5p 外,没有一个 miRNA 在血浆外泌体中显著上调,而 miR-93-5p 具有边缘显著性(16 例 LSCC 与 16 例 NC)。总之,我们的研究建立了一个四 miRNA 外周血浆特征,在一定程度上有助于诊断中国男性 LSCC 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/76820cc9c450/CAM4-7-2370-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/e1593ae41803/CAM4-7-2370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/33d7b3864ed4/CAM4-7-2370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/dd42a0374b40/CAM4-7-2370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/bb6bfc02bdfa/CAM4-7-2370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/76820cc9c450/CAM4-7-2370-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/e1593ae41803/CAM4-7-2370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/33d7b3864ed4/CAM4-7-2370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/dd42a0374b40/CAM4-7-2370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/bb6bfc02bdfa/CAM4-7-2370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad4/6010830/76820cc9c450/CAM4-7-2370-g005.jpg

相似文献

1
Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.鉴定出 4 个血浆 microRNAs,作为中国男性肺鳞癌患者诊断的潜在生物标志物。
Cancer Med. 2018 Jun;7(6):2370-2381. doi: 10.1002/cam4.1490. Epub 2018 Apr 19.
2
A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.血浆中七种 miRNA 特征组成的 panel 作为结直肠癌诊断的潜在生物标志物。
Gene. 2019 Mar 1;687:246-254. doi: 10.1016/j.gene.2018.11.055. Epub 2018 Nov 17.
3
A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.血浆中的一种六微小RNA特征被鉴定为食管鳞状细胞癌诊断中的一种潜在生物标志物。
Oncotarget. 2017 May 23;8(21):34468-34480. doi: 10.18632/oncotarget.16519.
4
A novel serum microRNA signature to screen esophageal squamous cell carcinoma.一种用于筛查食管鳞状细胞癌的新型血清微小RNA标志物。
Cancer Med. 2017 Jan;6(1):109-119. doi: 10.1002/cam4.973. Epub 2016 Dec 30.
5
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.鉴定血浆中的 7 个 microRNA 特征作为鼻咽癌检测有前途的生物标志物。
Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19.
6
A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.血浆中的一个包含六种微小RNA的组合被确定为肺腺癌诊断的潜在生物标志物。
Oncotarget. 2017 Jan 24;8(4):6513-6525. doi: 10.18632/oncotarget.14311.
7
A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.一个用于诊断中国患者甲状腺乳头状癌的三血浆 microRNA 特征。
Gene. 2019 Apr 20;693:37-45. doi: 10.1016/j.gene.2019.01.016. Epub 2019 Jan 24.
8
A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.用于中国男性患者肺鳞状细胞癌诊断的三微小RNA标志物
Oncotarget. 2017 Jul 28;8(49):86897-86907. doi: 10.18632/oncotarget.19666. eCollection 2017 Oct 17.
9
Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma.血清微小RNA表达谱揭示肺腺癌潜在诊断生物标志物
Chin Med J (Engl). 2020 Nov 5;133(21):2532-2542. doi: 10.1097/CM9.0000000000001100.
10
MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.血清中微小 RNA 表达谱分析在鼻咽癌诊断中的应用。
Gene. 2020 Feb 15;727:144243. doi: 10.1016/j.gene.2019.144243. Epub 2019 Nov 16.

引用本文的文献

1
Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy.源自间歇性缺氧非小细胞肺癌的外泌体miR-106a-5p会增加肿瘤恶性程度。
Physiol Rep. 2024 Aug;12(15):e16157. doi: 10.14814/phy2.16157.
2
Matrix metalloproteinase‑1 and microRNA‑486‑5p in urinary exosomes can be used to detect early lung cancer: A preliminary report.尿外泌体中的基质金属蛋白酶-1和微小RNA-486-5p可用于早期肺癌检测:初步报告
Oncol Lett. 2024 Jan 29;27(3):127. doi: 10.3892/ol.2024.14261. eCollection 2024 Mar.
3
Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer.

本文引用的文献

1
A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.用于中国男性患者肺鳞状细胞癌诊断的三微小RNA标志物
Oncotarget. 2017 Jul 28;8(49):86897-86907. doi: 10.18632/oncotarget.19666. eCollection 2017 Oct 17.
2
Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.微小RNA作为乳腺癌全身治疗反应的潜在预测指标:未来的临床意义
Int J Mol Sci. 2017 Jun 2;18(6):1182. doi: 10.3390/ijms18061182.
3
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.
外泌体 microRNA 治疗非小细胞肺癌。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231210731. doi: 10.1177/15330338231210731.
4
The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review.外泌体 miRNA 作为癌症早期检测生物标志物的新兴作用:全面文献综述。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231205999. doi: 10.1177/15330338231205999.
5
Role of miR‑181a‑5p in cancer (Review).miR-181a-5p 在癌症中的作用(综述)。
Int J Oncol. 2023 Oct;63(4). doi: 10.3892/ijo.2023.5556. Epub 2023 Aug 4.
6
lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis.长链非编码RNA ASBEL和长链非编码RNA Erbb4-IR通过微小RNA-21/LZTFL1轴降低IV期肺鳞状细胞癌对吉西他滨和顺铂的化疗耐药性。
Am J Cancer Res. 2023 Jun 15;13(6):2732-2750. eCollection 2023.
7
Integrated Tissue and Blood miRNA Expression Profiles Identify Novel Biomarkers for Accurate Non-Invasive Diagnosis of Breast Cancer: Preliminary Results and Future Clinical Implications.整合组织和血液 miRNA 表达谱可准确无创诊断乳腺癌:初步结果和未来临床意义。
Genes (Basel). 2022 Oct 24;13(11):1931. doi: 10.3390/genes13111931.
8
Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer Patients.健康对照者与早期肺癌患者游离循环和囊泡相关血浆微小RNA的比较分析
Pharmaceutics. 2022 Sep 23;14(10):2029. doi: 10.3390/pharmaceutics14102029.
9
Contributions of Circulating microRNAs for Early Detection of Lung Cancer.循环微RNA在肺癌早期检测中的作用
Cancers (Basel). 2022 Aug 30;14(17):4221. doi: 10.3390/cancers14174221.
10
MicroRNA-106a-5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK.微小RNA-106a-5p通过靶向LKB1/AMPK促进肺腺癌细胞的增殖、自噬和迁移。
Exp Ther Med. 2021 Dec;22(6):1422. doi: 10.3892/etm.2021.10857. Epub 2021 Oct 11.
一项前瞻性队列研究中血浆微小RNA作为胰腺癌风险生物标志物的研究
Int J Cancer. 2017 Sep 1;141(5):905-915. doi: 10.1002/ijc.30790. Epub 2017 Jun 12.
4
Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.转移性黑色素瘤切除术后的血浆微小RNA水平
Bioinform Biol Insights. 2017 Feb 23;11:1177932217694837. doi: 10.1177/1177932217694837. eCollection 2017.
5
A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.血浆中的一种六微小RNA特征被鉴定为食管鳞状细胞癌诊断中的一种潜在生物标志物。
Oncotarget. 2017 May 23;8(21):34468-34480. doi: 10.18632/oncotarget.16519.
6
A panel of microRNA signature in serum for colorectal cancer diagnosis.用于结直肠癌诊断的血清微小RNA特征组合
Oncotarget. 2017 Mar 7;8(10):17081-17091. doi: 10.18632/oncotarget.15059.
7
A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.血浆中的一个包含六种微小RNA的组合被确定为肺腺癌诊断的潜在生物标志物。
Oncotarget. 2017 Jan 24;8(4):6513-6525. doi: 10.18632/oncotarget.14311.
8
Prognostic value of candidate microRNAs in gastric cancer: A validation study.候选微小RNA在胃癌中的预后价值:一项验证研究。
Cancer Biomark. 2017;18(3):221-230. doi: 10.3233/CBM-160091.
9
A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.一组13种微小RNA特征作为预测胰腺癌生存率的潜在生物标志物。
Oncotarget. 2016 Oct 25;7(43):69616-69624. doi: 10.18632/oncotarget.11903.
10
Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.肺腺癌肿瘤、癌旁及正常组织中差异表达的微小RNA
Biomed Res Int. 2016;2016:1428271. doi: 10.1155/2016/1428271. Epub 2016 May 10.